Patent classifications
A61F2002/821
STENT DEVICE INCLUDING A FLARABLE CROWN
A stent device is provided. The stent device includes: at least one radially expandable body portion extending along a longitudinal axis of the stent device defining a lumen; and at least one outwardly flarable portion connected to the body portion. The outwardly flarable portion includes at least one radially expandable ring connected to the body portion and at least one flaring connector connected to the at least one ring configured to cause a crown of the at least one ring to automatically flare radially outwardly relative to other portions of the ring upon radial expansion of the body portion so as to form a flared crown. After radial expansion, the outwardly flaring portion may be held in place by a support strut that lessens its ability to collapse. A method of deploying the stent device is also provided.
Device and method for a safe positioning of a coronary stent in coronary arteries
The invention is suitable for use in medicine for maximally precise, safe and quick positioning a coronary stent in case of simple and complicated anatomical lesions of the coronary bed as well as for stenting renal, visceral arteries. The claimed device comprise a body with a tail portion, a screw rotation wheel, a screw, a slider with a cam, a bush with clip and a rubber coupling provided thereon, a wedge comprised of two members, a spring and a lock button arranged in the body. In preparation to use the device, the coronary stent on the delivery system is first successively introduced into the device whereafter the coronary stent on the delivery system is manually advanced to the affected area of the coronary artery, the delivery system is locked in the device and the stent is positioned within the coronary artery by means of the rotation wheel.
TOOL FOR PLACEMENT OF DEGRADEABLE OSTIAL STENT
A hand-held device is used to deliver and hydrate a temporary polymeric implant having a length, an outer surface and a cross-section, with a disruptable cover over the implant. A lumen may pass through the entire length, the lumen having a surface forming an equivalent diameter in the polymeric stent. The temporary polymeric implant includes a first aqueous-swellable, biocompatible and biodegradable composition (e.g., polymer) having a thickness. The aqueous-swellable and biodegradable polymer retaining structural integrity for at least 1 hours up to thirty days when swollen and kept moist by a moist aqueous environment. Barrier layers of biodegradable polymer(s) may be used to prevent migration of liquids into the lumen.
VASCULAR STENT
A vascular stent, including a plurality of wave-shaped supporters connected in an axial direction. The tubular stent includes a proximal support mechanism, a middle support mechanism, and a differential support mechanism connected in sequence; the middle support mechanism and the distal support mechanism are respectively closed-loop structure; the proximal support mechanism includes a first support portion connected to the middle support mechanism and a second support portion provided at the proximal end of the first support portion; the first support portion is a closed-loop structure; the second support portion is an open-loop structure, and the end surface of the proximal end of the second support portion is an uneven structure to provide local support in the circumferential direction.
SYSTEM AND METHOD FOR DEPLOYING A PROXIMALLY-FLARING STENT
Disclosed herein are proximally-flaring stents and balloon catheter systems and methods for using the same to restore patency to a side branch and its ostium at a vessel bifurcation, where the side branch can only be approached from the direction of the main artery. The system and methods include a proximally-flaring stent and one or more balloon catheters with inflatable balloons that are able to push a flanged proximal portion of the proximally-flaring stent entirely against the artery walls of the main artery of the side branch so that blood flow is not occluded.
STENT TO ASSIST IN ARTERIOVENOUS FISTULA FORMATION
There is described an arteriovenous fistula stent, having a tubular body comprising a series of sinusoidal shaped struts along the length of the tubular body. A plurality of curvilinear connectors extend between and are attached to adjacent struts wherein a first end of a connector is attached to a distal face of a proximal strut apex and a second end of a connector is attached to a proximal face of a distal strut apex. A pair of unconnected strut apexes are between pairs of connected apexes. When the tubular body is in a stowed configuration a proximal aperture and a distal aperture are circular and when the tubular body is in a deployed configuration the distal aperture is oblong or ovoid. There is also described a method for inserting a stent for use in creation of an arteriovenous fistula by identifying a candidate artery and a candidate vein and dissecting the candidate vein. Next, inserting a stent into the vein and creating a breach in the candidate artery at a desired angle and location. Next, introducing the stent and vein into the candidate artery and forming the stent into a curvature angle selected to minimize turbulent blood flow in an anastomosis formed by the vein and the artery. Optionally, there is a step of fastening a distal portion of the stent to the artery.
DEVICE AND METHOD FOR PREVENTING STENOSIS AT AN ANASTOMOSIS SITE
The present invention relates to treating or preventing stenosis at an anastomosis site. In one embodiment, the present invention is a stent is curved along the longitudinal axis for placement in and adjacent to the graft orifice. In a further embodiment, the stent is drug coated to allow delivery of antivasculoproliferative drugs directly to the vicinity of the graft orifice. In a further embodiment, the stent is expandable by use of an external wire. In another embodiment, the present invention is a kit comprising the specially configured stent together with a sleeve comprising a biocompatible matrix material and a pharmaceutical agent, wherein the sleeve is applied to the external surface of the vessel or graft, resulting in extravascular delivery of a pharmaceutical agent. Methods for treating or preventing stenosis at an anastomosis site by applying the extravascular sleeve and the intravascular stent are also provided.
Stent with polymer coating containing amorphous rapamycin
A coated coronary stent, comprising a stainless steel sent framework coated with a primer layer of Parylene C, and a rapamycin-polymer coating having substantially uniform thickness disposed on the stent framework, wherein the rapamycin-polymer coating comprises polybutyl methacrylate (PBMA), polyethylene-co-vinyl acetate (PEVA) and rapamycin, wherein substantially all of the rapamycin in the coating is in amorphous form and substantially uniformly dispersed within the rapamycin-polymer coating.
Branch stent
This disclosure relates to a stent for use in vascular interventions, the stent comprising a first portion for placing in a first lumen and a second portion for placing in a region of a branch point at which the first lumen branches off a second lumen, the second portion comprising one or more rings linked by second links to the first portion and, if the second portion comprises two or more rings, together. The first and second portions are configured to be different to facilitate controlled longitudinal deformation of the second portion.
ENDOLUMINAL PROSTHESIS HAVING MULTIPLE BRANCHES OR FENESTRATIONS AND METHODS OF DEPLOYMENT
A branched and fenestrated prosthesis may include a main tubular graft body including a proximal end opening, a distal end opening, a lumen, and a sidewall. A branch may extend from the sidewall and may include a first end opening, a second end opening, and a lumen. A fenestration may be disposed in the sidewall and positioned distal of the second end opening of the branch. The branched and fenestrated prosthesis may include a plurality of branches and a plurality of fenestrations.